KATHLEEN LONG: Open Payments
NPI 1982003885 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 31 payments from 8 companies in 2025. Trend: 2023 $258 · 2024 $436 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $193 |
| Novo Nordisk Inc | 6 | $113 |
| Lilly USA, LLC | 4 | $61 |
| Insulet Corporation | 1 | $43 |
| Exact Sciences Corporation | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Viatris Specialty LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: UBRELVY, QULIPTA, MOUNJARO, Omnipod, Wegovy, VRAYLAR, The Cologuard Plus Collection Kit, Rybelsus.
Industry payments across AL — which companies pay providers there.
